- Advertisement -

Related

Hedge funds make biotech all the rage

- Advertisement -

The search for new investment opportunities has lead the hedge fund industry to assist an investment boom in the biotech sector

The following is according to a story by Financial Times, published on August 2. Equity issuance in

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

HedgeNordic Editorial Team
HedgeNordic Editorial Team
This article was written, or published, by the HedgeNordic editorial team.

Latest Articles

Impega Stays Selective as Fear and Greed Drive Markets

His long-biased equity fund, Impega, is up more than 75 percent in the first half of the year, making it by far the best-performing...

Chelonia Select Stands Out in Difficult July

With the Nordic hedge fund industry broadly in negative territory during July, strong performers were relatively scarce. Among the standouts was stock-picking hedge fund...

DNB TMT Defies Tech Sell-Off in July

July does not appear to have been a particularly strong month for the Nordic hedge fund industry. One notable exception is DNB TMT Long/Short...

Norwegian Hedge Funds Double Assets Since 2020

The Norwegian hedge fund industry has emerged as the standout performer in the Nordic region in recent years, translating strong returns into rapid asset...

Global Hedge Fund Assets Hit Record $5.6 Trillion

Global hedge fund assets climbed to a record $5.6 trillion at the end of the second quarter, driven by a combination of strong investment...

Lynx Delivers Second-Best First Half in 25-Year History

The Lynx Program posted a strong first half of 2026, returning 25.9 percent, its second-best first-half performance in its 25-year history. Lynx Asset Management’s...

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -